Clinical Trials Browser

Phase 3 × BF-200 ALA × Dermatologic × Clear all

NCT05662202 2026-02-19

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Phase 3 Active not recruiting

Keratosis, Actinic

NCT02144077 2022-11-03

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

Phase 3 Completed

281 enrolled 16 charts

Carcinoma, Basal Cell

NCT02799069 2017-04-28

Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy

Phase 3 Completed

571 enrolled 46 charts

Keratosis, Actinic